Home
>
National Drug Code (NDC)
>
NUCYNTA
NUCYNTA - 50458-863-02 - (tapentadol hydrochloride)
Drug Information of NUCYNTA
| Product NDC: | 50458-863 |
| Proprietary Name: | NUCYNTA |
| Non Proprietary Name: | tapentadol hydrochloride |
| Active Ingredient(s): | 200 mg/1 & nbsp; tapentadol hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of NUCYNTA
| Product NDC: | 50458-863 |
| Labeler Name: | Janssen Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA200533 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20110825 |
Package Information of NUCYNTA
| Package NDC: | 50458-863-02 |
| Package Description: | 10 BLISTER PACK in 1 BOX, UNIT-DOSE (50458-863-02) > 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK |
NDC Information of NUCYNTA
| NDC Code | 50458-863-02 |
| Proprietary Name | NUCYNTA |
| Package Description | 10 BLISTER PACK in 1 BOX, UNIT-DOSE (50458-863-02) > 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK |
| Product NDC | 50458-863 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | tapentadol hydrochloride |
| Dosage Form Name | TABLET, FILM COATED, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20110825 |
| Marketing Category Name | NDA |
| Labeler Name | Janssen Pharmaceuticals, Inc. |
| Substance Name | TAPENTADOL HYDROCHLORIDE |
| Strength Number | 200 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Opioid Agonist [EPC],Opioid Agonists [MoA] |
